These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites. Dunwiddie CT; Neeper MP; Nutt EM; Waxman L; Smith DE; Hofmann KJ; Lumma PK; Garsky VM; Vlasuk GP Biochemistry; 1992 Dec; 31(48):12126-31. PubMed ID: 1457408 [TBL] [Abstract][Full Text] [Related]
7. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis. Orvim U; Barstad RM; Vlasuk GP; Sakariassen KS Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2188-94. PubMed ID: 7489241 [TBL] [Abstract][Full Text] [Related]
8. A novel process for the large-scale purification of recombinant tick anticoagulant peptide using perfusion chromatography. Lehman ED; Joyce JG; Freymeyer DK; Bailey FJ; Herber WK; Miller WJ Biotechnology (N Y); 1993 Feb; 11(2):207-12. PubMed ID: 7763373 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic efficacy of recombinant tick anticoagulant peptide. A potent inhibitor of coagulation factor Xa in a primate model of arterial thrombosis. Schaffer LW; Davidson JT; Vlasuk GP; Siegl PK Circulation; 1991 Oct; 84(4):1741-8. PubMed ID: 1833089 [TBL] [Abstract][Full Text] [Related]
10. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide. Hagemeyer CE; Tomic I; Jaminet P; Weirich U; Bassler N; Schwarz M; Runge MS; Bode C; Peter K Thromb Haemost; 2004 Jul; 92(1):47-53. PubMed ID: 15213844 [TBL] [Abstract][Full Text] [Related]
11. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. Krishnaswamy S; Vlasuk GP; Bergum PW Biochemistry; 1994 Jun; 33(25):7897-907. PubMed ID: 8011652 [TBL] [Abstract][Full Text] [Related]
12. NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata. Antuch W; Güntert P; Billeter M; Hawthorne T; Grossenbacher H; Wüthrich K FEBS Lett; 1994 Sep; 352(2):251-7. PubMed ID: 7925983 [TBL] [Abstract][Full Text] [Related]
13. Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. Jordan SP; Mao SS; Lewis SD; Shafer JA Biochemistry; 1992 Jun; 31(23):5374-80. PubMed ID: 1606162 [TBL] [Abstract][Full Text] [Related]
14. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171 [TBL] [Abstract][Full Text] [Related]
15. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Waxman L; Smith DE; Arcuri KE; Vlasuk GP Science; 1990 May; 248(4955):593-6. PubMed ID: 2333510 [TBL] [Abstract][Full Text] [Related]
16. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Ragosta M; Gimple LW; Gertz SD; Dunwiddie CT; Vlasuk GP; Haber HL; Powers ER; Roberts WC; Sarembock IJ Circulation; 1994 Mar; 89(3):1262-71. PubMed ID: 8124815 [TBL] [Abstract][Full Text] [Related]
17. Structural and functional characterization of tick anticoagulant peptide (TAP): a potent and selective inhibitor of blood coagulation factor Xa. Vlasuk GP Thromb Haemost; 1993 Jul; 70(1):212-6. PubMed ID: 8236107 [TBL] [Abstract][Full Text] [Related]
18. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae. Lehman ED; Joyce JG; Bailey FJ; Markus HZ; Schultz LD; Dunwiddie CT; Jacobson MA; Miller WJ Protein Expr Purif; 1993 Jun; 4(3):247-55. PubMed ID: 8518563 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis. Fioravanti C; Burkholder D; Francis B; Siegl PK; Gibson RE Thromb Res; 1993 Aug; 71(4):317-24. PubMed ID: 8236160 [TBL] [Abstract][Full Text] [Related]
20. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Cappello M; Vlasuk GP; Bergum PW; Huang S; Hotez PJ Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6152-6. PubMed ID: 7597095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]